With the highest professional and ethical standards, we commercialise therapies and technologies that uniquely fulfil the unmet medical needs of our community.

HCP Portal & Access Programs

ST therapies have been used to treat

~160,000

patients

ST has donated
more than

$38.1 million

worth of drugs to patients at no cost on compassionate grounds

ST has contributed
more than

$5.4 million

to research and development

ST has provided
more than

$2.4 million

in donations, grants and sponsorship to organisations aligned with its focus and mission

ST has established partnerships with

18

international companies, commercialising their therapies in key regions

Meeting the unmet needs of patients in Australia, New Zealand and Southeast Asia

Our Partners

We collaborate with international partner companies , championing their speciality products from pre-registration through to full commercialisation

We are a member of World Orphan Drug Alliance (WODA), an international consortium of pharmaceutical companies established to improve access to new treatments for rare diseases

More Info